Applied dna to provide covid-19 surveillance testing to stony brook basketball

Stony brook, n.y.--(business wire)---- $apdn #covid19--applied dna sciences, inc. (nasdaq: apdn) (“applied dna” or the "company"), a leader in polymerase chain reaction (pcr)-based dna manufacturing, announced that its wholly-owned subsidiary, applied dna clinical laboratories, llc (“adcl”), will provide its covid-19 surveillance testing program to the stony brook university seawolves men's and women's basketball teams. adcl's pooled surveillance testing platform, known as safecircle™, will aid the safe return to
APDN Ratings Summary
APDN Quant Ranking